Two of them received filgastrim during the acute episode of neutropenia and all five patients had long-acting G-CSF with the subsequent chemotherapy (without treatment delay) administrations in prevention of febrile neutropenia or dose delays. The gene discussed is CSF3; the disease is Decreased total neutrophil count.